QIAGEN IPA

QIAGEN Ingenuity Pathway Analysis CaseStudy_CD155 Expression in Metastatic Melanoma and Anti-PD1 resistance

293 views
October 14, 2020
In this video, Eric Seiser, Ph.D, Sr. Field Application Scientist will be demonstrating a use case of QIAGEN Ingenuity Pathway Analysis for interpreting the biology of gene expression based omics dataset. The focus will be on a recent study on a potential therapeutic target CD155 for Metastatic Melanoma patients that demonstrate resistance to Anti-PD1 based therapies

Related videos

QIAGEN IPA

New user training: Large dataset analysis and knowledgebase queries using QIAGEN IPA- February 17

235 views February 20, 2021

In this 90-minute video, users will take a deeper dive into core analysis,...

QIAGEN IPA

New user training: Large dataset analysis and knowledgebase queries using QIAGEN IPA- February 16

242 views February 20, 2021

In this 90-minute video, new users will learn - how to upload their dataset...

QIAGEN IPA

Multi omics analysis using QIAGEN Ingenuity Pathway Analysis (IPA) - Feb 18

312 views February 20, 2021

This 90-minute training session is about how QIAGEN Ingenuity Pathway...

QIAGEN IPA

New user training: Large dataset analysis and knowledge base queries using QIAGEN IPA - March 16...

134 views March 20, 2021

This 90-minute training session is for new users on QIAGEN IPA. New users...